Bleichroeder LP Bluebird Bio, Inc. Transaction History

Bleichroeder LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$0.91 - $1.75 $1.33 Million - $2.56 Million	-1,462,621 Reduced 58.5%	1,037,379 $1.33 Million
Q4 2023 Feb 12, 2024	BUY	$1.32 - $4.83 $2.11 Million - $7.73 Million	1,600,000 Added 177.78%	2,500,000 $3.45 Million
Q3 2023 Nov 09, 2023	BUY	$3.02 - $4.05 $2.72 Million - $3.65 Million	900,000 New	900,000 $2.74 Million
Q1 2021 May 17, 2021	SELL	$16.59 - $33.89 $414,750 - $847,250	-25,000 Closed	0 $0
Q2 2020 Aug 12, 2020	BUY	$27.12 - $45.97 $678,000 - $1.15 Million	25,000 New	25,000 $1.53 Million

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

Stay updated on Bleichroeder LP with notifications on news.